Patents by Inventor Robert E. Atkinson

Robert E. Atkinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160183953
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing a first intravascular device having a distal portion with a concave side, inserting the first device into the vascular lumen, positioning the distal portion in the vascular wall, and orienting the concave side of the distal portion toward the vascular lumen.
    Type: Application
    Filed: March 7, 2016
    Publication date: June 30, 2016
    Applicant: BRIDGEPOINT MEDICAL, INC.
    Inventors: CHAD J. KUGLER, MATTHEW J. OLSON, ROBERT E. ATKINSON
  • Patent number: 9308126
    Abstract: Improvements in devices, systems and methods for non-invasively lowering intra-ocular pressure (IOP). In examples, the device applies non-invasive, focal, mechanical oscillation to the limbal region at a low amplitude and frequency, targeting the trabecular meshwork to restore outflow function and lower IOP.
    Type: Grant
    Filed: September 8, 2014
    Date of Patent: April 12, 2016
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Malik Y. Kahook, Glenn R. Sussman, Robert E. Atkinson
  • Patent number: 9308019
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing a first intravascular device having a distal portion with a concave side, inserting the first device into the vascular lumen, positioning the distal portion in the vascular wall, and orienting the concave side of the distal portion toward the vascular lumen.
    Type: Grant
    Filed: July 23, 2013
    Date of Patent: April 12, 2016
    Assignee: BridgePoint Medical, Inc.
    Inventors: Chad J. Kugler, Matthew J. Olson, Robert E. Atkinson
  • Publication number: 20160089178
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.
    Type: Application
    Filed: December 10, 2015
    Publication date: March 31, 2016
    Applicant: Bridgepoint Medical, Inc.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Patent number: 9289287
    Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: March 22, 2016
    Assignees: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporate
    Inventors: Malik Y. Kahook, Naresh Mandava, Glenn Sussman, Paul McLean, Robert E. Atkinson
  • Patent number: 9237897
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.
    Type: Grant
    Filed: January 10, 2014
    Date of Patent: January 19, 2016
    Assignee: Bridgepoint Medical, Inc.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Publication number: 20160008172
    Abstract: Devices, systems and methods are taught herein for non-invasively lowering intra-ocular pressure (IOP). In examples, the device applies non-invasive, focal, mechanical oscillation to the limbal region of the eye at a low amplitude and frequency, targeting the trabecular meshwork to restore outflow function and lower IOP.
    Type: Application
    Filed: September 24, 2015
    Publication date: January 14, 2016
    Inventors: Malik Y. Kahook, Glenn R. Sussman, Robert E. Atkinson
  • Publication number: 20150342729
    Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary lens for stability. Such attachment may reside radially inside the perimeter of the capsulorhexis and radially outside the field of view to avoid interference with light transmission.
    Type: Application
    Filed: July 24, 2015
    Publication date: December 3, 2015
    Inventors: Malik Y. Kahook, Naresh Mandava, Paul McLean, Robert E. Atkinson
  • Patent number: 9125736
    Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary lens for stability. Such attachment may reside radially inside the perimeter of the capsulorhexis and radially outside the field of view to avoid interference with light transmission.
    Type: Grant
    Filed: July 9, 2013
    Date of Patent: September 8, 2015
    Assignees: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporate
    Inventors: Malik Y. Kahook, Naresh Mandava, Paul McLean, Robert E. Atkinson
  • Patent number: 9095424
    Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary lens for stability. Such attachment may reside radially inside the perimeter of the capsulorhexis and radially outside the field of view to avoid interference with light transmission.
    Type: Grant
    Filed: January 23, 2013
    Date of Patent: August 4, 2015
    Assignees: ClarVista Medical, Inc., The Regents of the University of Colorado
    Inventors: Malik Y. Kahook, Naresh Mandava, Paul McLean, Robert E. Atkinson
  • Publication number: 20150196424
    Abstract: Improvements in devices, systems and methods for non-invasively lowering intra-ocular pressure (IOP). In examples, the device applies non-invasive, focal, mechanical oscillation to the limbal region at a low amplitude and frequency, targeting the trabecular meshwork to restore outflow function and lower IOP.
    Type: Application
    Filed: September 8, 2014
    Publication date: July 16, 2015
    Inventors: Malik Y. KAHOOK, Glenn R. SUSSMAN, Robert E. ATKINSON
  • Publication number: 20150164785
    Abstract: Devices and methods for less invasively treating the gastrointestinal system, such as the intestinal mucosa of the small bowel. Embodiments described herein may be used to reduce caloric absorption and effectuate weight loss, for example.
    Type: Application
    Filed: December 15, 2014
    Publication date: June 18, 2015
    Inventors: Chad J. Kugler, Robert E. Atkinson, Peter T. Keith
  • Publication number: 20150080928
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes inserting an intramural crossing device into the vascular lumen, positioning at least the distal tip of the crossing device in the vascular wall, advancing an orienting device over the crossing device such that an orienting element of the orienting device resides in the vascular wall, inserting a reentry device, and re-entering the true vascular lumen.
    Type: Application
    Filed: November 25, 2014
    Publication date: March 19, 2015
    Inventors: Chad J. Kugler, Robert E. Atkinson, Matthew J. Olson
  • Patent number: 8961494
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes inserting an intramural crossing device into the vascular lumen, positioning at least the distal tip of the crossing device in the vascular wall, advancing an orienting device over the crossing device such that an orienting element of the orienting device resides in the vascular wall, inserting a re-entry device, and re-entering the true vascular lumen.
    Type: Grant
    Filed: October 25, 2012
    Date of Patent: February 24, 2015
    Assignee: BridgePoint Medical, Inc.
    Inventors: Chad J. Kugler, Robert E. Atkinson, Matthew J. Olson
  • Patent number: 8744589
    Abstract: A method of stimulating a nerve of a patient. The method may include positioning a first electrode set on a first portion of the nerve, wherein the first portion of the nerve innervates a first upper airway muscle of the patient. The method may include positioning a second electrode set on a second portion of the nerve, wherein the second portion of the nerve innervates a second upper airway muscle of the patient. The method may further include alternatively delivering an electrical stimulation to the first electrode set and to the second electrode set.
    Type: Grant
    Filed: December 29, 2010
    Date of Patent: June 3, 2014
    Assignee: Cyberonics, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Patent number: 8718783
    Abstract: A method of stimulating a hypogossal nerve including chronically implanting a nerve cuff electrode on a portion of the hypoglossal nerve. The method may further include sensing a signal corresponding to respiration and detecting expiratory onset from the sensed signal. Moreover, the method may include delivering a stimulus to the portion of the hypoglossal nerve via the nerve cuff electrode, wherein the stimulus is delivered as a function of the detected expiratory onset.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: May 6, 2014
    Assignee: Cyberonics, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Publication number: 20140121689
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.
    Type: Application
    Filed: January 10, 2014
    Publication date: May 1, 2014
    Applicant: Bridgepoint Medical, Inc.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Publication number: 20140052246
    Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.
    Type: Application
    Filed: August 16, 2013
    Publication date: February 20, 2014
    Applicants: THE REGENTS OF THE UNIVERSITY OF COLORADO AND CLARVISTA MEDICAL, INC. a body corporate, CLARVISTA MEDICAL, INC.
    Inventors: Malik Y. KAHOOK, Naresh MANDAVA, Glenn SUSSMAN, Paul McLEAN, Robert E. ATKINSON
  • Patent number: 8636712
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: January 28, 2014
    Assignee: Bridgepoint Medical, Inc.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Patent number: 8639354
    Abstract: In an embodiment, a lead system includes a cuff electrode to secure to a nerve, a first lead portion defining a longitudinal axis, and a second lead portion. An anchor may be between the first lead portion and the second lead portion to secure to non-nerve structure. A connector may extend from the second lead portion to connect to a pulse generator. Electrode elements are spaced apart along the cuff body. The cuff electrode may include a first resilient arcuate-shaped portion extending in a first circumferential direction and having a first arc length; and a second resilient arcuate-shaped portion integrally formed with the first arcuate-shaped portion, extending in a second circumferential direction, and having a second arm length greater that the first arc length. The second arcuate-shaped portion overlaps the first arcuate-shaped portion, The first and second arcuate-shaped portions define a lumen having a substantially re-closable opening.
    Type: Grant
    Filed: October 3, 2011
    Date of Patent: January 28, 2014
    Assignee: Cyberonics, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar